Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neurobiol Learn Mem ; 131: 18-25, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26968655

RESUMEN

Spermidine (SPD) is an endogenous aliphatic amine that modulates GluN2B-containing NMDA receptors and improves memory. Recent evidence suggests that systemic SPD improves the persistence of the long term memory of fear. However, the role of hippocampal polyamines and its binding sites in the persistence of fear memory is to be determined, as well as its putative underlying mechanisms. This study investigated whether the intrahippocampal (i.h.) infusion of spermidine or arcaine, modulators of polyamine binding site at GluN2B-containing NMDA receptors, alters the persistence of the memory of contextual fear conditioning task in rats. We also investigated whether protein synthesis and cAMP dependent protein kinase (PKA) play a role in SPD-induced improvement of the fear memory persistence. While 12h post-training infusion of spermidine facilitated, arcaine and the inhibitor of protein synthesis (anisomycin) impaired the memory of fear assessed 7days after training. The infusion of arcaine, anisomycin or a selective PKA inhibitor (H-89), at doses that have no effect on memory per se, prevented the SPD-induced improvement of memory persistence. H-89 prevented the stimulatory effect of SPD on phospho-PKA/total-PKA ratio. These results suggests that the improvement of fear memory persistence induced by spermidine involves GluN2B-containing NMDA receptors, PKA pathway and protein synthesis in rats.


Asunto(s)
Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Miedo/fisiología , Hipocampo/efectos de los fármacos , Memoria a Largo Plazo/efectos de los fármacos , Nootrópicos/farmacología , Poliaminas/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de la Síntesis de la Proteína/farmacología , Espermidina/farmacología , Animales , Anisomicina/administración & dosificación , Anisomicina/farmacología , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Biguanidas/administración & dosificación , Biguanidas/farmacología , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Isoquinolinas/administración & dosificación , Isoquinolinas/farmacología , Masculino , Nootrópicos/administración & dosificación , Inhibidores de Proteínas Quinasas/administración & dosificación , Inhibidores de la Síntesis de la Proteína/administración & dosificación , Ratas , Ratas Wistar , Espermidina/administración & dosificación , Sulfonamidas/administración & dosificación , Sulfonamidas/farmacología
2.
Epilepsy Res ; 105(3): 396-400, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23602551

RESUMEN

The present study aimed to investigate whether Na(+),K(+)-ATPase activity and phosphorylation state of the catalytic α subunit are altered by pentylenetetrazol (PTZ)-induced seizures. PTZ (30, 45 or 60 g/kg, i.p.) was administered to adult male Swiss mice, and Na(+),K(+)-ATPase activity and phosphorylation state were measured in the cerebral cortex 15 min after PTZ administration. Na(+),K(+)-ATPase activity significantly decreased after PTZ-induced seizures (60 mg/kg). Immunoreactivity of phosphorylated Ser943 at α subunit was increased after PTZ-induced seizures. A significant positive correlation between Na(+),K(+)-ATPase activity and latency to myoclonic jerks and generalized seizures was found. Conversely, a strong negative correlation between Ser943 phosphorylation and latency to generalized seizures was detected. Given the role of Na(+),K(+)-ATPase as a major regulator of brain excitability, Ser943 at Na(+),K(+)-ATPase α subunit may represent a potentially valuable new target for drug development for seizure disorders.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/enzimología , Convulsivantes/toxicidad , Pentilenotetrazol/toxicidad , Convulsiones/inducido químicamente , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Fosforilación/efectos de los fármacos , Subunidades de Proteína/metabolismo , Tiempo de Reacción/efectos de los fármacos , Convulsiones/patología , Serina/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA